Titre:
  • Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.
Auteur:De Moerloose, Barbara; Suciu, Stefan; Bertrand, Yves; Mazingue, F; Robert, Alain; Uyttebroeck, A; Yakouben, Karima; Ferster, Alina; Margueritte, Geneviève; Lutz, Pierre; Munzer, Martine; Sirvent, Nicolas; Norton, Lucilia; Boutard, Patrick; Plantaz, D; Millot, Frédéric; Philippet, Pierre; Baila, Liliana; Benoît, Yves; Otten, Jacques; Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC),
Informations sur la publication:Blood, 116, 1, page (36-44)
Statut de publication:Publié, 2010-07
Sujet CREF:Cancérologie
Pédiatrie
Hématologie
MeSH keywords:Vincristine -- administration & dosage
Note générale:Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0006-4971
info:doi/10.1182/blood-2009-10-247965
info:pii/blood-2009-10-247965
info:pmid/20407035
PMC2904579